Class 4 medicines defect information – Inhixa solution for injection pre-filled syringe
19 Apr 2018
A Class 4 medicines defect information alert has been issued by the MHRA for all strengths of Inhixa solution for injection in pre-filled syringe.
DRUG ALERT
Class 4 medicines defect information – Caution in Use
Ref: EL (18)A/07
18 April 2018
Inhixa (enoxaparin sodium) solution for injection pre-filled syringe:
2,000iu (20mg) in 0.2ml – EU/1/16/1132/012
4,000iu (40 mg) in 0.4ml – EU/1/16/1132/014
6,000iu (60 mg) in 0.6ml – EU/1/16/1132/016
8,000iu (80 mg) in 0.8ml – EU/1/16/1132/018
10,000iu (100 mg) in 1.0ml – EU/1/16/1132/020(Manufactured by Techdow Europe AB)
A Class 4 medicines defect information alert has been issued by the Medicines & Healthcare products Regulatory Agency (MHRA) for all strengths of Inhixa (enoxaparin sodium) solution for injection in pre-filled syringe.
Further information can be found on the MHRA section on the GOV.UK website.
Produced by the NPA Pharmacy team April 2018.